Hospital
Sparrow Carson Hospital
Sparrow Carson Hospital was paid $5.48M by Medicaid between Jan 2018 and Dec 2024, across 131 billing codes. Its largest line is 99285, emergency room visit (most serious) — 23% of everything it billed.
33Billing provider infoSPARROW CARSON HOSPITAL
CARSON CITY, MI 48811
CARSON CITY, MI 48811
33aNPI1336103043assigned 04/12/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$5.48M
24GClaims152,047
24DCodes billed131
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Michigan
Rank by total paid#70 of 86
Median peer was paid$21.55M
This provider vs. median0.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official RUSSIAN, MISTY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,616 | $672K | |
| 2019 | 18,833 | $603K | |
| 2020 | 17,474 | $582K | |
| 2021 | 25,986 | $911K | |
| 2022 | 28,569 | $1.01M | |
| 2023 | 26,457 | $952K | |
| 2024incomplete | 20,112 | $744K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 23% | 4,071 | 3,818 | $1.27M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 20% | 9,122 | 8,713 | $1.12M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 16% | 4,670 | 4,485 | $881K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 6.2% | 3,445 | 3,189 | $340K |
| 62323 | 5.3% | 975 | 956 | $289K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.0% | 2,352 | 2,296 | $167K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.3% | 2,715 | 2,630 | $125K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2.2% | 2,083 | 2,025 | $122K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.0% | 741 | 723 | $107K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.7% | 2,862 | 2,565 | $94K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.5% | 856 | 778 | $85K |
| 64493 | 1.2% | 154 | 150 | $66K |
119 more codes
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,983 | $54K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,242 | $52K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 2,254 | $50K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,250 | $43K |
| 80061 | Lipid panel | <1% | 4,594 | $39K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 811 | $39K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 430 | $38K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 5,350 | $34K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,416 | $34K |
| 80053 | Comprehensive metabolic panel | <1% | 13,638 | $34K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,187 | $30K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,081 | $28K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 366 | $28K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 256 | $26K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 1,404 | $19K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 1,799 | $19K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 11,455 | $19K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 1,370 | $19K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,107 | $15K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,219 | $15K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 223 | $12K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 50 | $11K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,079 | $11K |
| 76830 | Ultrasound, transvaginal | <1% | 177 | $10K |
| 84439 | <1% | 2,131 | $9K | |
| M0245 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | <1% | 28 | $8K |
| 82607 | <1% | 1,138 | $6K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,031 | $5K |
| 73610 | <1% | 272 | $5K | |
| 20610 | <1% | 51 | $5K | |
| 73630 | <1% | 368 | $4K | |
| 86803 | <1% | 600 | $4K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,224 | $4K |
| 82728 | <1% | 612 | $4K | |
| 97161 | <1% | 66 | $3K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 437 | $3K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,336 | $3K |
| 85027 | <1% | 2,216 | $3K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 24 | $3K |
| 87077 | <1% | 1,162 | $3K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 245 | $3K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,208 | $3K |
| 83550 | <1% | 688 | $3K | |
| 87210 | <1% | 1,110 | $2K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 24 | $2K |
| 83540 | <1% | 814 | $2K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 39 | $2K |
| 82652 | <1% | 149 | $2K | |
| 73130 | <1% | 121 | $2K | |
| 81514 | <1% | 13 | $2K | |
| 82043 | <1% | 1,013 | $2K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 161 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 626 | $2K |
| 87186 | <1% | 778 | $2K | |
| 82570 | <1% | 980 | $2K | |
| 73562 | <1% | 111 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,009 | $2K |
| 87625 | <1% | 79 | $1K | |
| 83721 | <1% | 386 | $1K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 25 | $1K |
| 73030 | <1% | 55 | $1K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 12 | $1K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,442 | $1K |
| 84703 | <1% | 2,585 | $885.25 | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 14 | $815.68 |
| 86140 | <1% | 1,403 | $770.87 | |
| 85610 | <1% | 1,422 | $725.47 | |
| 76801 | <1% | 13 | $699.12 | |
| 0002A | <1% | 20 | $690.28 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 93 | $654.95 |
| 83735 | <1% | 1,558 | $650.58 | |
| 86900 | <1% | 14 | $463.97 | |
| 74018 | <1% | 24 | $429.60 | |
| 87070 | <1% | 136 | $410.53 | |
| 83690 | <1% | 1,732 | $395.52 | |
| 0001A | <1% | 17 | $336.85 | |
| 81001 | <1% | 3,322 | $333.63 | |
| 87420 | <1% | 439 | $306.59 | |
| 83880 | <1% | 291 | $238.38 | |
| 85730 | <1% | 798 | $236.75 | |
| 87510 | <1% | 42 | $226.29 | |
| 87480 | <1% | 42 | $226.29 | |
| 84478 | <1% | 97 | $202.53 | |
| 86780 | <1% | 25 | $181.61 | |
| 84702 | <1% | 31 | $129.71 | |
| 85652 | <1% | 148 | $109.67 | |
| 83516 | <1% | 12 | $89.46 | |
| 85007 | <1% | 134 | $87.88 | |
| 81003 | <1% | 1,330 | $84.68 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 82 | $81.97 |
| 87660 | <1% | 13 | $63.01 | |
| 84484 | <1% | 1,473 | $33.14 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,139 | $32.30 |
| 82947 | <1% | 18 | $25.50 | |
| 86038 | <1% | 13 | $21.61 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,854 | $12.00 |
| 85379 | <1% | 13 | $7.77 | |
| 83605 | <1% | 406 | $7.62 | |
| 99152 | <1% | 2,015 | $7.13 | |
| Q0245 | Injection, bamlanivimab and etesevimab, 2100 mg | <1% | 28 | $6.13 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 162 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 1,530 | $0.00 |
| 64494 | 0% | 107 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 55 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 96 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 0% | 454 | $0.00 |
| 96376 | 0% | 103 | $0.00 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 360 | $0.00 |
| 87040 | 0% | 12 | $0.00 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 0% | 169 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 14 | $0.00 |
| 82962 | 0% | 86 | $0.00 | |
| 86901 | 0% | 14 | $0.00 | |
| 86850 | 0% | 14 | $0.00 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 1,177 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 920 | $0.00 |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 0% | 77 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 318 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRUSSIAN, MISTY (SUPERVISOR, PROVIDER ENROLLMENT)
Parent organizationSPARROW HEALTH SYSTEM
| Provider | Location | Paid |
|---|---|---|
| Edward W Sparrow Hospital Association | Lansing, MI | $125.88M |
| Metropolitan Hospital | Wyoming, MI | $100.96M |
| Sparrow Ionia Hospital | Ionia, MI | $13.76M |
| Sparrow Eaton Hospital | Charlotte, MI | $13.22M |
| Sparrow Clinton Hospital | Saint Johns, MI | $8.68M |
| Edward W. Sparrow Hospital Association | Lansing, MI | $5.81M |
| Edward W. Sparrow Hospital Association | East Lansing, MI | $5.43M |
| Sparrow Ionia Hospital | Ionia, MI | $3.49M |
| Sparrow Eaton Hospital | Charlotte, MI | $3.12M |
| Edward W. Sparrow Hospital Association | Lansing, MI | $2.77M |
| Edward W. Sparrow Hospital Association | Lansing, MI | $2.61M |
| Edward W Sparrow Hospital Association | Lansing, MI | $2.48M |
| Edward W. Sparrow Hospital Association | Mason, MI | $2.44M |
| Sparrow Community Care | Lansing, MI | $2.31M |
| Edward W Sparrow Hospital Association | Lansing, MI | $2.31M |
| Edward W Sparrow Hospital Association | Lansing, MI | $1.85M |
| Edward W. Sparrow Hospital Association | Lansing, MI | $1.83M |
| Edward W. Sparrow Hospital Association | Lansing, MI | $1.65M |
| Sparrow Ionia Hospital | Portland, MI | $1.61M |
| Sparrow Carson Hospital | Ithaca, MI | $1.54M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.